Comparison of Three Botulinum Neuromodulators for Management of Facial Synkinesis

NCT03048383 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Facial Nerve Injuries
Facial Paresis Associated With Facial Nerve Dysfunction
Facial Asymmetry
Synkinesis

Interventions

DRUG: OnabotulinumtoxinA Injectable Product
DRUG: AbobotulinumtoxinA Injectable Product
DRUG: Incobotulinumtoxin A Injectable Product

Sponsor

University of Utah